Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dame Kay Davies, Dr Lee’s Professor of Anatomy here in DPAG, has been working on a clinical trial that today announced a potentially life-changing discovery.

Summit Therapeutics, the drug discovery and development company advancing therapies for rare diseases and infectious diseases, for which Professor Davies is a co-founder, have released the interim results from the trial, PhaseOut DMD, which had been evaluating the effect of ezutromid in patients with Duchenne muscular dystrophy, DMD.

Discoveries show that ezutromid does indeed reduce muscle damage significantly in DMD patients; a total of 14 out of 22 patients showed a decrease in developmental myosin, a biomarker of muscle damage, with five of those patients showing a greater than 40% reduction.

DMD is a progressive muscle wasting disease that affects around 50,000 boys and young men in the developed world. The results from the trial suggest a potential universal treatment for DMD, since there is currently no cure for DMD and life expectancy is into the late twenties.

Professor Davies is delighted at the results from the trial, saying: These data provide the first evidence of utrophin modulation working in patients. If further findings build on this evidence they could establish ezutromid as a universal, disease-modifying treatment and bring hope to all patients and families living with DMD.

Similar stories

Professor Dame Sue Black to deliver 2022 Christmas Lectures

In the 2022 Christmas Lectures from the Royal Institution, DPAG's Visiting Professor of Forensic Anatomy Dame Sue Black will share secrets of forensic science.

Kaitlyn Dennis to receive the William C Stanley Early Investigator Award

Congratulations are in order for DPhil student Kaitlyn Dennis, who has been awarded the William C Stanley Early Investigator Award. The award highlights the scientific accomplishments of promising young researchers and is a major focus of the Annual Meeting of the Society for Heart and Vascular Metabolism.

Becky Carlyle funded by leading dementia research charity to reveal new targets for Alzheimer's

Senior Postdoctoral Research Scientist Dr Becky Carlyle has been awarded a £420K funding boost from Alzheimer’s Research UK.

Researchers describe how cancer cells can defend themselves from the consequences of certain genetic defects

Swietach Group scientists have identified a rescue mechanism that allows cancers to overcome the consequences of inactivating mutations in critically important genes.

Professor Dame Sue Black joins DPAG as Visiting Professor of Forensic Anatomy

The Department welcomes Professor Dame Sue Black DBE OBE FRSE FBA FRAI FRSB ChFA, Baroness Black of Strome and one of the world’s leading forensic scientists, as our Visiting Professor of Forensic Anatomy.